Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
3.13M
-
Shares change
-
+1.97M
-
Total reported value, excl. options
-
$1.4M
-
Value change
-
+$874K
-
Number of buys
-
4
-
Number of sells
-
-8
-
Price
-
$0.45
Significant Holders of HCW Biologics Inc. - COM (HCWB) as of Q4 2024
20 filings reported holding HCWB - HCW Biologics Inc. - COM as of Q4 2024.
HCW Biologics Inc. - COM (HCWB) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.13M shares
.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (2.02M shares), Avantax Planning Partners, Inc. (280K shares), GEODE CAPITAL MANAGEMENT, LLC (182K shares), HighTower Advisors, LLC (181K shares), Cresset Asset Management, LLC (132K shares), Pullen Investment Management, LLC (75.1K shares), BlackRock, Inc. (43K shares), VANGUARD GROUP INC (37.7K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (34.7K shares), and XTX Topco Ltd (34K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.